ARPC1A and neoplasm: In summary, our study supports targeting Arp2/3 complex subunits as a novel anticancer strategy, highlights the prognostic and diagnostic value of ARPC1A across cancers, and emphasizes the connections between ARPC1A, oxidative phosphorylation, and tumor immunity.